Search results
Added:
1 week ago
HRS Congress 2026 — In this Arrhythmia Academy expert interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr. Pasquale Santangeli (Cleveland Clinic, Ohio, USA) about six-month outcomes from the Sphere-9 VT early feasibility study.They review the Affera Sphere-9 lattice tip catheter and mapping-ablation system, a dual-energy, large…
View more
Added:
3 months ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented…
View more
Added:
1 year ago
HRS 25 - First-in-human study demonstrates successful implantation of a novel leadless pacemaker with clinically acceptable intraprocedural electrical performance and safety.We are joined by Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, US) to discuss the findings from a feasibility study investigating the safety and performance of a novel helix-based leadless pacemaker with…
View more
Added:
1 year ago
EHRA 2025 - Follow-up outcomes of a balloon-in-basket pulsed field ablation (PFA) system for pulmonary vein isolation (PVI) show high acute PVI isolation rates and a low adverse event rate. Overall, the balloon-in-basket PFA system proved to be a safe and feasible treatment option for PVI.Prof Roland Tilz (University Heart Centre Lübeck, Lübeck, Germany) joins us on-site at EHRA Congress 2025 to…
View more
Added:
1 year ago
HRS 2025 - First-in-human three-month results from a contact force-sensing catheter integrated with 3D mapping to treat paroxysmal atrial fibrillation (PAF) show potential for high acute effectiveness and a promising safety profile.Dr Mattias Duytschaever (St Jan Hospital, Bruges, BE) joins us to discuss the three-month findings from the first-in-human Omny-IRE study (NCT05971693; Biosense…
View more
Added:
1 year ago
ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life.We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East…
View more
Added:
1 year ago
HRS 24 - Dr Larry Chinitz (NYU School of Medicine, US) joins us to discuss the findings of the prospective, multicenter BIO-CONDUCT study, which investigated the safety and efficacy of the BIOTRONIK Solia S pacing lead implanted in the left bundle branch area (LBB) (NCT05251363, Biotronik Inc.). 186 patients with atrioventricular block, bradycardia, left bundle-branch block or cardiomyopathies…
View more
Start date:
Oct 17, 2024
This one-hour virtual program will feature presentations and interactive discussion focused on the recently presented data on PulseSelect PFA system and new clinical research on durability with PFA. We will also discuss efficiency workflow tips and a multi-user center’s real-world experience.UC202503229 EN
View more
Added:
1 year ago
Added:
6 months ago
AHA 2025 - Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) joins us to share findings from the PFA-SHAM study (NCT05717725) investigating pulsed field ablation (PFA) versus sham ablation to treat AF. Patients enrolled in the study underwent an electrophysiology study to ensure they had no concealed AV bypass tract or supraventricular tachycardia, and patients were then…
View more